Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1337 |
| Name of the vaccine | Meningo A+C |
| Microbe | Bacteria |
| Disease name | Meningococcal disease |
| Name of bacteria | Neisseria meningitidis |
| Type of vaccine | Polysaccharide |
| Nucleic acid content | DNA |
| Age | 2 to 6 years |
| Description of the vaccine | Meningococcal (groups A and C) polysaccharide vaccine by Sanofi Pasteur. |
| Name of the manufacturer | Sanofi Pasteur, a Sanofi Company |
| Name of the manufacturing country | China |
| Year of manufacture | 2012 |
| Clinical Phase status | Clinical - Phase 4 |
| Bacterial strain | Gram-negative diplococcus. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | Single dose of 0.5 mL. |
| Mechanism of action | NA |
| Route of administration | Subcutaneous |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | For Meningitis also. |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Single dose |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT01430611 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |